$21.92
0.341.58%
最終更新: Sep 22, 1:19 PM
Benzinga
Benzinga
Benzinga
火曜日, 9 22
Viridian Therapeutics Inc
VRDNNASDAQ
Viridian Therapeutics Earnings & Forecasts
Viridian Therapeutics (VRDN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Viridian Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.02 | $-1.07 | $-0.96 | $-0.89 |
| Actual | $-1.05 | $-0.90 | $-1.08 | $-0.34 |
| Surprise | -2.94% | +15.9% | -12.5% | +61.8% |
| Revenue | ||||
| Estimate | $22000 | $27750 | $16.8M | $25.7M |
| Actual | $233000 | $141000 | $132000 | $70570 |
| Surprise | +959.1% | +408.1% | -99.2% | -99.7% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.01 | $-0.99 | $-0.73 | $-0.59 |
| Revenue | ||||
| Consensus | $8.7M | $18.3M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved